Mohamed Shamiya, MD
Sleep Medicine · Las Vegas, NVNPI 1467731505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 30.7% of the total. 2025 is the largest year on record at $570, more than ten times the $29 reported in 2022.
Across 31 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$295
- Itamar Medical Inc$163
- Avadel CNS Pharmaceuticals, LLC$126
- Lilly USA, LLC$125
- Harmony Biosciences LLC$109
- Axsome Therapeutics, Inc.$85
- plus $57 from 1 others
What the payments were for
- Food & beverage$960100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 7 | $295 |
| Itamar Medical Inc | 2 | $163 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $126 |
| Lilly USA, LLC | 6 | $125 |
| Harmony Biosciences LLC | 5 | $109 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| Inspire Medical Systems, Inc. | 2 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WatchPATONE$139
- XYWAV$122
How this compares
Too few sleep medicine providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 58 | $1,124 |
| Modafinil | 14 | $391 |
| Ropinirole Hcl | 31 | $243 |
| Bupropion Hcl SrBupropion Hcl | 13 | $65 |
| Gabapentin | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Las Vegas
- Tara RachakondaLas Vegas$6K
- Clifford MolinLas Vegas$4K
- Hala SammanLas Vegas$388
- Robert ReynaLas Vegas$70
- Umar NasirReno$6K
- Brandon FloresReno$5K
- Kimberly YeagerReno$4K
- Francis Paul BattungReno$2K
- Alexander BlatyNorth Las Vegas$2K
- William TorchReno$297
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.